Cargando…

Assessment of mOMV adjuvant efficacy in the pathogenic H1N1 influenza virus vaccine

PURPOSE: Since the pandemic (H1N1) 2009 virus has been a seasonal flu which still poses great human health concerns worldwide, vaccination would be considered as the most effective strategy to control the influenza virus spreading. Here, we assessed adjuvant efficacy of modified outer membrane vesic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Byeong-Jae, Kwon, Hyeok-il, Kim, Eun-Ha, Park, Su-Jin, Lee, Sang-Ho, Choi, Young Ki, Kim, Sang-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Vaccine Society 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083072/ https://www.ncbi.nlm.nih.gov/pubmed/25003093 http://dx.doi.org/10.7774/cevr.2014.3.2.194

Ejemplares similares

Pathogenicity and genetic characterisation of a novel reassortant, highly pathogenic avian influenza (HPAI) H5N6 virus isolated in Korea, 2017
por: Kim, Young-Il, et al.
Publicado: (2018)

Altered virulence of Highly Pathogenic Avian Influenza (HPAI) H5N8 reassortant viruses in mammalian models
por: Park, Su-Jin, et al.
Publicado: (2017)

Functionalization of OMVs for Biocatalytic Applications
por: Amalia, Lita, et al.
Publicado: (2023)

Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV
por: Shehata, Mahmoud M., et al.
Publicado: (2019)

Genetic characterisation of novel, highly pathogenic avian influenza (HPAI) H5N6 viruses isolated in birds, South Korea, November 2016
por: Si, Young-Jae, et al.
Publicado: (2017)

Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
por: Behrouzi, Ava, et al.
Publicado: (2020)

Development of ssDNA Aptamers for Diagnosis and Inhibition of the Highly Pathogenic Avian Influenza Virus Subtype H5N1
por: Kim, Sang-Heon, et al.
Publicado: (2020)

Emergence of H3N2pM‐like and novel reassortant H3N1 swine viruses possessing segments derived from the A (H1N1)pdm09 influenza virus, Korea
por: Pascua, Philippe Noriel Q., et al.
Publicado: (2013)

Pathobiological features of a novel, highly pathogenic avian influenza A(H5N8) virus
por: Kim, Young-Il, et al.
Publicado: (2014)

Comparison of the virulence and transmissibility of canine H3N2 influenza viruses and characterization of their canine adaptation factors
por: Lee, In-Won, et al.
Publicado: (2018)

Caveolin-1 regulates OMV-induced macrophage pro-inflammatory activation and multiple Toll-like receptors
por: Sivanantham, Ayyanar, et al.
Publicado: (2023)

Breaking the bilayer: OMV formation during environmental transitions
por: Bonnington, Katherine E., et al.
Publicado: (2017)

OMV Vaccines and the Role of TLR Agonists in Immune Response
por: Mancini, Francesca, et al.
Publicado: (2020)

Comparison of the pathogenic potential of highly pathogenic avian influenza (HPAI) H5N6, and H5N8 viruses isolated in South Korea during the 2016–2017 winter season
por: Kwon, Hyeok-il, et al.
Publicado: (2018)

Interspecies Outer Membrane Vesicles (OMVs) Modulate the Sensitivity of Pathogenic Bacteria and Pathogenic Yeasts to Cationic Peptides and Serum Complement
por: Roszkowiak, Justyna, et al.
Publicado: (2019)

Complete Genome Sequences of Novel Reassortant H1N2 Swine Influenza Viruses Isolated from Pigs in the Republic of Korea
por: Pascua, Philippe Noriel Q., et al.
Publicado: (2013)

Clinical characteristics of children with 2009 pandemic influenza A (H1N1) admitted in a single institution
por: Park, Sang In, et al.
Publicado: (2010)

Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination
por: Ko, Eun-Ju, et al.
Publicado: (2017)

Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza
por: Jang, Jin-Wook, et al.
Publicado: (2017)

Symptomatic Differences between Influenza A/H3N2 and A/H1N1 in Korea
por: Lee, Hyun-Jong, et al.
Publicado: (2023)

Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients
por: Moon, Sung Jin, et al.
Publicado: (2012)

Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2019)

An OMV-Based Nanovaccine Confers Safety and Protection against Pathogenic Escherichia coli via Both Humoral and Predominantly Th1 Immune Responses in Poultry
por: Hu, Rujiu, et al.
Publicado: (2020)

Highly Pathogenic Avian Influenza Virus (H5N1) in Domestic Poultry and Relationship with Migratory Birds, South Korea
por: Lee, Youn-Jeong, et al.
Publicado: (2008)

Evaluation of a protective effect of in ovo delivered Campylobacter jejuni OMVs
por: Godlewska, Renata, et al.
Publicado: (2016)

Predatory Strategies of Myxococcus xanthus: Prey Susceptibility to OMVs and Moonlighting Enzymes
por: Zwarycz, Allison S., et al.
Publicado: (2023)

Experimental infection of chickens, ducks and quails with the highly pathogenic H5N1 avian influenza virus
por: Jeong, Ok-Mi, et al.
Publicado: (2009)

BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection
por: Kim, Ki-Hye, et al.
Publicado: (2021)

A Novel Neuraminidase-Dependent Hemagglutinin Cleavage Mechanism Enables the Systemic Spread of an H7N6 Avian Influenza Virus
por: Kwon, Hyeok-il, et al.
Publicado: (2019)

Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets
por: Kim, Eun-Ha, et al.
Publicado: (2015)

Initial dose cascade of TTS fentanyl with proper adjuvant medications in cancer pain.
por: Baik, Seong Wan, et al.
Publicado: (2003)

Synergism Between Bacterial GAPDH and OMVs: Disparate Mechanisms but Co-Operative Action
por: Whitworth, David E., et al.
Publicado: (2015)

Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update
por: Jan, Arif Tasleem
Publicado: (2017)

Helicobacter pylori-Derived Outer Membrane Vesicles (OMVs): Role in Bacterial Pathogenesis?
por: Jarzab, Miroslaw, et al.
Publicado: (2020)

Heterologous Display of Chlamydia trachomatis PmpD Passenger at the Surface of Salmonella OMVs
por: Huynh, Dung T., et al.
Publicado: (2023)

An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea
por: Choi, Jun Gu, et al.
Publicado: (2008)

In-Flight Transmission of Novel Influenza A (H1N1)
por: Kim, Joon Hyung, et al.
Publicado: (2010)

Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza a virus in mice
por: Kim, Eun-Ha, et al.
Publicado: (2013)

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
por: Kang, Yoon-Koo, et al.
Publicado: (2021)

Gianotti-Crosti Syndrome Following Novel Influenza A (H1N1) Vaccination
por: Kwon, Na Hyun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_efmg3muk70enpi76pknd5l1hf7